Skip to main content
The Journal of Physiology logoLink to The Journal of Physiology
. 2018 Jul 17;596(16):3433–3437. doi: 10.1113/JP275425

CrossTalk proposal: mucosal acidification drives early progressive lung disease in cystic fibrosis

Miriam F Figueira 1, Megan J Webster 1, Robert Tarran 1,2,
PMCID: PMC6092275  PMID: 30014571

Introduction

Cystic fibrosis (CF) is the most common life‐threatening inherited disorder affecting Caucasians. It is caused by mutations in the CFTR gene that generate impaired cystic fibrosis transmembrane regulator (CFTR) anion channels leading to a multi‐organ disease including chronic airway infection/lung deterioration and increased morbidity/mortality (Fajac & Wainwright, 2017). Despite identification of the CF gene in 1989, the initial phases of CF lung disease remain controversial (Luckie & Mauri, 2013). One of the biggest questions is how the loss of CFTR‐mediated anion secretion initiates chronic lung infections. It has been known since the early 1990s that CFTR can conduct HCO3 and that CF epithelia exhibit defective bicarbonate transport (Gray et al. 1990; Smith & Welsh, 1992; Poulsen et al. 1994). Based on studies in CF piglets and in primary CF airway cultures, it is thought that CF airways are not hyperinflammatory and that the observed increase in inflammation is consequent to infections (Becker et al. 2004; Stoltz et al. 2010). Multiple laboratories have concluded that mucosal acidification drives early progressive lung disease in CF (Gustafsson et al. 2012; Pezzulo et al. 2012; Garland et al. 2013). However, whether or not CF airway surface liquid (ASL) is actually acidic is controversial (Schultz et al. 2017). Nonetheless, reduced ASL HCO3 is receiving more recognition as a key contributor towards early CF lung pathology.

CFTR is permeable to chloride and bicarbonate

HCO3 permeability through CFTR is ∼20% that of Cl (P HCO 3/P HCO 3P Cl P Cl ∼0.2) (Gray et al. 1990; Poulsen et al. 1994). However, CFTR may have a dynamic selectivity to HCO3 that could differ under physiological conditions (Reddy & Quinton, 2003; Shcheynikov et al. 2004). Furthermore, CFTR can regulate and/or be regulated by the SLC26A family of Cl/ HCO3 exchangers (Ko et al. 2002; Gray, 2004; Tuo et al. 2006) and cytokines can alter bicarbonate secretion (Gray et al. 2004; Adams et al. 2014), suggesting that HCO3 transport is variable. Importantly, cAMP‐regulated short‐circuit current was partially HCO3 ‐dependent in non‐CF human bronchial epithelial cultures (HBECs) but was absent in CF HBECs (Smith & Welsh, 1992).

HCO3 deficiency drives pancreatic pathology

The pancreas is the organ most affected by CF, and pancreatic destruction begins in utero in CF patients with severe CFTR mutations. Here, CFTR‐mediated Cl is used as the counter on during Cl/HCO3 exchange to facilitate the HCO3 secretion required to neutralize digestive enzymes and prevent auto‐digestion of the pancreas (Borowitz, 2015). CF pancreatic disease correlates with the level of HCO3 secretion and the severity of the CFTR mutation, indicating that altered HCO3 transport can drive CF pathology (Choi et al. 2001).

Is there a HCO3 gradient?

Garland et al. (2013) reported that ASL pH was significantly different in the unperturbed ASL of primary normal and CF HBECs, similar to the pH found in nasal secretions from NL vs. CF subjects (i.e. 7.0 and 6.5, respectively). Similarly, ASL pH was lower in newborn CF vs. wild‐type piglets (Pezzulo et al. 2012). In contrast, Schultz et al. (2017) recently found no difference between normal and CF ASL pH in paediatric lower airways. The relative sensitivity of their probe vs. the filter paper and other methods of detecting pH remains to be validated by independent groups. Interestingly, they also found no difference in ASL pH in airway cultures. However, an important methodological difference here is that they did not use primary (i.e. non‐passaged cultures) and instead used conditionally reprogrammed (i.e. expanded cultures) (Schultz et al. 2017). This method leads to a significant decrease in CFTR activity (≥50% reduction in forskolin‐sensitive Cl current) and an increase in transepithelial resistance, suggesting that ion transport properties have been compromised (Gentzsch, et al. 2017). An extensive list of CF ASL pH measurements has previously been excellently compiled elsewhere (Luckie & Mauri, 2013). Airway epithelia have high water permeability (Matsui et al. 2000; Song et al. 2001) and paracellular pathways that are permeable to ions including HCO3 (Cotton et al. 1983; Coakley et al. 2003). One might expect ASL [H+] and [HCO3 ] to be isotonic with plasma, resulting in an ASL pH of 7.4 and [HCO3 ] of ∼25 mm (assuming that ASL PCO2 is 5%). However, based on measures of normal ASL pH (i.e. ∼7.0); (Garland et al. 2013; Schultz et al. 2017), according to the Henderson–Hasselbalch equation, with 5% CO2, ASL [HCO3 ] should be ∼10 mm. With pH 6.5, ASL [HCO3 ] is estimated to be ∼3 mm. Thus, there is a mucosal to serosal HCO3 gradient in normal airways of ∼15 mm and CF epithelia may support an ∼22 mm gradient (Fig. 1). Airway epithelia can secrete protons via dual oxidases (DUOX) and the non‐gastric H+/K+‐ATPase (ATP12A) (Coakley et al. 2003; Fischer, 2009). Indeed rates of proton secretion are greater than paracellular bicarbonate diffusion in CF airway epithelia, which results in ASL acidification (Fischer, 2009). Furthermore, K+ gradients have been detected between ASL and plasma of ∼20 mm in vivo, suggesting that transepithelial ion gradients of 10–20 mm can be supported (Knowles et al. 1997).

Figure 1. ASL pH and HCO3 transport in airway epithelia.

Figure 1

Cartoon illustrating transcellular and paracellular HCO3 transport in normal airway epithelia (A) and CF airway epithelia (B). HCO3 traverses the basolateral membrane via the Na+/HCO3 and Cl/HCO3 cotransporters. In normal airway epithelia, apical HCO3 transport is mediated via CFTR and SLC26A4. However CFTR is absent or defective in CF airway epithelia. HCO3 , amongst other ions, is able to diffuse paracellularly. HCO3 becomes protonated within the ASL following the paracellular movement of and transcellular flux of H+ by H+ channels and the H+/K+‐ATPase, to produce H2O and CO2. Equilibrium between HCO3 and H+ is such that normal ASL pH is ∼7.0. Despite the exaggerated HCO3 gradient evident across CF epithelia, ASL pH is acidified to ∼6.5 due to proton flux through via dual oxidase (DUOX).

What are the consequences of acidic ASL pH?

Determining [ion] in the thin (∼7 μm) ASL in vivo is technically challenging, and even relatively abundant Cl has proved troublesome to measure (Guggino, 1999). However, despite these difficulties, pH‐sensitive changes to airway physiology are readily apparent and the absence of bicarbonate is predicted to impair epithelial function (Saint‐Criq & Gray, 2017). At the most basic level, tertiary protein structure is often pH sensitive and changes in pH can affect protein unfolding (Talley & Alexov, 2010; Moon & Fleming, 2011). Similarly, acidic pH alters protein function. For example, cathepsins are more active at acidic pH, which may lead to increased activation of the epithelial Na+ channel (ENaC) and greater protease‐induced damage in CF airways (Martin et al. 2010; Tan et al. 2014). Work by our group has demonstrated that the abundant innate defence protein short palate lung and nasal epithelial clone 1 (SPLUNC1) is highly pH sensitive (Garland et al. 2013). SPLUNC1's crystal structure revealed the presence of pH‐sensitive salt bridges that prevented SPLUNC1–ENaC interactions at acidic pH (Hobbs et al. 2013; Garland et al. 2013). Thus, SPLUNC1 cannot bind to and inhibit ENaC at acidic pH leading to CF ASL dehydration (Garland et al. 2013; Tarran & Redinbo, 2014). Similarly, the amiloride‐sensitive nasal potential difference (an in vivo indicator of ENaC activity) was reduced at moderately acidic pH (Garland et al. 2013).

Goblet cells use Ca2+ to cross‐link and densely pack mucins. Following the exchange of Ca2+ for Na+, mucins expand ∼800 times due to the lack of cross linking (Verdugo, 1991). However, HCO3 can influence Ca2+ activity and may hinder the Ca2+/Na+‐exchange process and limit mucin expansion, causing mucins to be secreted without fully unfolding, leading to impaired rheology and reduced mucus clearance (Dorschner et al. 2006; Quinton, 2017).

A neutral ASL pH is also optimal for antimicrobial actions (Bahar & Ren, 2013; Berkebile & McCray, 2014). In addition to reports of antimicrobial peptides being pH sensitive (Zasloff, 1992; Burkhard, 1996; Bals et al. 1999), ASL antimicrobial activity was also pH sensitive and impaired in CF piglet ASL (Pezzulo et al. 2012), suggesting that a moderately acidic pH will also impair anti‐bacterial actions in the lung.

Thus, three arms of the lung's innate defence system, hydration, mucus rheology and antimicrobial activity, can be impaired by small reductions in ASL pH. Importantly, it is likely that the mucus clearance system, which requires coordinated CFTR and ENaC activity as well as correct mucin expansion, and the antimicrobial system work in concert to prevent bacterial colonization. That is, mucus clearance physically clears bacteria while antimicrobial proteins/peptides prevent bacterial growth, and pH‐sensitive inhibition of all of these processes would be more serious for CF pathogenesis than if just one arm of the innate defence system were abrogated.

Gastro‐oesophageal reflux and CF lung disease

Gastro‐oesophageal reflux occurs in up to 60% of adults over any 12 months (Zhao & Encinosa, 2006). In CF, there is a similar incidence (Robinson & DiMango, 2017). During gastro‐oesophageal reflux, the highly acidic stomach contents reflux into the airways, especially at night when subjects are prone. Irrespective of the absolute difference in ASL pH, Coakley et al. (2003) noted that CF HBECs recovered from a mucosal acidic challenge more slowly than non‐CF HBECs in the absence of CFTR‐mediated bicarbonate secretion, indicating that CF subjects are more at risk of gastro‐oesophageal reflux‐induced airway acidification since they cannot rapidly neutralize their airways after an acid challenge. Thus, transient ASL acidification due to gastro‐oesophageal reflux may temporarily exacerbate pH‐sensitive innate lung defence, leading to lasting lung damage.

Closing remarks

In summary, a little change in pH goes a long way. Compelling information from the airways shows how small changes in the pH can alter multiple processes, leading to chronic infections in CF lungs. Given the ‘noise’ that is inherent in most in vivo measurements, a ∼15 mm difference in bicarbonate may be difficult to detect, but the physiological impact of this change is readily apparent.

Call for comments

Readers are invited to give their views on this and the accompanying CrossTalk articles in this issue by submitting a brief (250 word) comment. Comments may be submitted up to 6 weeks after publication of the article, at which point the discussion will close and the CrossTalk authors will be invited to submit a ‘LastWord’. Please email your comment, including a title and a declaration of interest, to jphysiol@physoc.org. Comments will be moderated and accepted comments will be published online only as ‘supporting information’ to the original debate articles once discussion has closed.

Additional information

Competing interests

None.

Author contributions

All authors have read and approved the final version of this manuscript and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All persons designated as authors qualify for authorship, and all those who qualify for authorship are listed.

Funding

This work was funded by Emily's Entourage and the Cystic Fibrosis Foundation.

Acknowledgements

We thank our colleagues in the Marsico Lung Institute for stimulating discussion regarding this topic.

Biographies

Miriam Figueira is a postdoctoral research associate in the Tarran Lab in the Marsico Lung Institute at the University of North Carolina. Her work focuses on studying how peptides can regulate the epithelial Na+ channel in severe cystic fibrosis lung disease.

graphic file with name TJP-596-3433-g001.gif

Megan Webster is a postdoctoral research associate in the Tarran Lab in the Marsico Lung Institute at the University of North Carolina. Her work focuses on the effects of the cystic fibrosis microenvironment on ion transport.

Robert Tarran is an associate professor of cell biology and physiology at the University of North Carolina and a member of the Marsico Lung Institute. He has a long standing interest in studying cystic fibrosis and tobacco‐related lung disease. His work currently focuses on the role of ion channels and secreted proteins in innate defence of the lung.

Linked articles This article is part of a CrossTalk debate. Click the links to read the other articles in this debate: https://doi.org/10.1113/JP276146, https://doi.org/10.1113/JP276145 and https://doi.org/10.1113/JP275426.

Edited by: Francisco Sepúlveda

References

  1. Adams KM, Abraham V, Spielman D, Kolls JK, Rubenstein RC, Conner GE, Cohen NA & Kreindler JL (2014). IL‐17A induces pendrin expression and chloride‐bicarbonate exchange in human bronchial epithelial cells. PLoS One 9, e103263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bahar AA & Ren D (2013). Antimicrobial peptides. Pharmaceuticals (Basel) 6, 1543–1575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bals R, Weiner DJ & Wilson JM (1999). The innate immune system in cystic fibrosis lung disease. J Clin Invest 103, 303–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Becker MN, Sauer MS, Muhlebach MS, Hirsh AJ, Wu Q, Verghese MW & Randell SH (2004). Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 169, 645–653. [DOI] [PubMed] [Google Scholar]
  5. Berkebile AR & McCray PB (2014). Effects of airway surface liquid pH on host defense in cystic fibrosis. Int J Biochem Cell Biol 52, 124–129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Borowitz D (2015). CFTR, bicarbonate, and the pathophysiology of cystic fibrosis. Pediatr Pulmonol 50 (Suppl 40), S24–S30. [DOI] [PubMed] [Google Scholar]
  7. Burkhard B (1996). Towards membrane protein design: pH‐sensitive topology of histidine‐containing polypeptides. J Mol Biol 263, 768–775. [DOI] [PubMed] [Google Scholar]
  8. Choi JY, Muallem D, Kiselyov K, Lee MG, Thomas PJ & Muallem S (2001). Aberrant CFTR‐dependent HCO3 transport in mutations associated with cystic fibrosis. Nature 410, 94–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coakley RD, Grubb BR, Paradiso AM, Gatzy JT, Johnson LG, Kreda SM, O'Neal WK & Boucher RC (2003). Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc Natl Acad Sci U S A 100, 16083–16088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cotton CU, Lawson EE, Boucher RC & Gatzy JT (1983). Bioelectric properties and ion transport of airways excised from adult and fetal sheep. J Appl Physiol 55, 1542–1549. [DOI] [PubMed] [Google Scholar]
  11. Dorschner RA, Lopez‐Garcia B, Peschel A, Kraus D, Morikawa K, Nizet V & Gallo RL (2006). The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J 20, 35–42. [DOI] [PubMed] [Google Scholar]
  12. Fajac I & Wainwright CE (2017). New treatments targeting the basic defects in cystic fibrosis. Presse Med 46, e165–e175. [DOI] [PubMed] [Google Scholar]
  13. Fischer H (2009). Mechanisms and function of DUOX in epithelia of the lung. Antioxid Redox Signal 11, 2453–2465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Garland AL, Walton WG, Coakley RD, Tan CD, Gilmore RC, Hobbs CA, Tripathy A, Clunes LA, Bencharit S, Stutts MJ, Betts L, Redinbo MR & Tarran R (2013). Molecular basis for pH‐dependent mucosal dehydration in cystic fibrosis airways. Proc Natl Acad Sci U S A 110, 15973–15978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gentzsch M, Boyles SE, Cheluvaraju C, Chaudhry IG, Quinney NL, Cho C, Dang H, Liu X, Schlegel R, Randell SH (2017). Pharmacological Rescue of Conditionally Reprogrammed Cystic Fibrosis Bronchial Epithelial Cells. Am J Respir Cell Mol Biol. 56, 568–574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gray MA (2004). Bicarbonate secretion: it takes two to tango. Nat Cell Biol 6, 292–294. [DOI] [PubMed] [Google Scholar]
  17. Gray MA, Pollard CE, Harris A, Coleman L, Greenwell JR & Argent BE (1990). Anion selectivity and block of the small‐conductance chloride channel on pancreatic duct cells. Am J Physiol 259, C752–C761. [DOI] [PubMed] [Google Scholar]
  18. Gray T, Coakley R, Hirsh A, Thornton D, Kirkham S, Koo J‐S, Burch L, Boucher R & Nettesheim P (2004). Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL‐1β in human bronchial epithelia. Am J Physiol Lung Cell Mol Physiol 286, L320–L330. [DOI] [PubMed] [Google Scholar]
  19. Guggino WB (1999). Cystic fibrosis and the salt controversy. Cell 96, 607–610. [DOI] [PubMed] [Google Scholar]
  20. Gustafsson JK, Ermund A, Ambort D, Johansson MEV, Nilsson HE, Thorell K, Hebert H, Sjövall H & Hansson GC (2012). Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J Exp Med 209, 1263–1272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hobbs CA, Blanchard MG, Alijevic O, Tan CD, Kellenberger S, Bencharit S, Cao R, Kesimer M, Walton WG, Henderson AG, Redinbo MR, Stutts MJ & Tarran R (2013). Identification of the SPLUNC1 ENaC‐inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol 305, L990–L1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Knowles MR, Robinson JM, Wood RE, Pue CA, Mentz WM, Wager GC, Gatzy JT & Boucher RC (1997). Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease‐control subjects. J Clin Invest 100, 2588–2595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ko SBH, Shcheynikov N, Choi JY, Luo X, Ishibashi K, Thomas PJ, Kim JY, Kim KH, Lee MG, Naruse S & Muallem S (2002). A molecular mechanism for aberrant CFTR‐dependent HCO3 transport in cystic fibrosis. EMBO J 21, 5662–5672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Luckie DB & Mauri E (2013). Cystic fibrosis: Does CFTR malfunction alter pH regulation? In Genetic Disorders, ed. Puiu M. IntechOpen, London: http://www.intechopen.com/books/genetic-disorders/cystic-fibrosis-does-cftr-malfunction-alter-ph-regulation-. [Google Scholar]
  25. Martin SL, Moffitt KL, McDowell A, Greenan C, Bright‐Thomas RJ, Jones AM, Webb AK & Elborn JS (2010). Association of airway cathepsin B and S with inflammation in cystic fibrosis. Pediatr Pulmonol 45, 860–868. [DOI] [PubMed] [Google Scholar]
  26. Matsui H, Davis CW, Tarran R & Boucher RC (2000). Osmotic water permeabilities of cultured, well‐differentiated normal and cystic fibrosis airway epithelia. J Clin Invest 105, 1419–1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Moon CP & Fleming KG (2011). Using tryptophan fluorescence to measure the stability of membrane proteins folded in liposomes. Methods Enzymol 492, 189–211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Pezzulo AA, Tang XX, Hoegger MJ, Abou Alaiwa MH, Ramachandran S, Moninger TO, Karp PH, Wohlford‐Lenane CL, Haagsman HP, van Eijk M, Bánfi B, Horswill AR, Stoltz DA, McCray PB, Welsh MJ & Zabner J (2012). Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 487, 109–113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Poulsen JH, Fischer H, Illek B & Machen TE (1994). Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A 91, 5340–5344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Quinton PM (2017). Both ways at once: keeping small airways clean. Physiology 32, 380–390. [DOI] [PubMed] [Google Scholar]
  31. Reddy MM & Quinton PM (2003). Control of dynamic CFTR selectivity by glutamate and ATP in epithelial cells. Nature 423, 756–760. [DOI] [PubMed] [Google Scholar]
  32. Robinson NB & DiMango E (2014). Prevalence of gastroesophageal reflux in cystic fibrosis and implications for lung disease. Ann Am Thorac Soc 11, 964–968. [DOI] [PubMed] [Google Scholar]
  33. Saint‐Criq V & Gray MA (2017). Role of CFTR in epithelial physiology. Cell Mol Life Sci 74, 93–115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schultz A, Puvvadi R, Borisov SM, Shaw NC, Klimant I, Berry LJ, Montgomery ST, Nguyen T, Kreda SM, Kicic A, Noble PB, Button B & Stick SM (2017). Airway surface liquid pH is not acidic in children with cystic fibrosis. Nat Commun 8, 1409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Shcheynikov N, Kim KH, Kim K, Dorwart MR, Ko SBH, Goto H, Naruse S, Thomas PJ & Muallem S (2004). Dynamic control of cystic fibrosis transmembrane conductance regulator selectivity by external Cl J Biol Chem 279, 21857–21865. [DOI] [PubMed] [Google Scholar]
  36. Smith JJ & Welsh MJ (1992). cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. J Clin Invest 89, 1148–1153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Song Y, Jayaraman S, Yang B, Matthay MA & Verkman AS (2001). Role of aquaporin water channels in airway fluid transport, humidification, and surface liquid hydration. J Gen Physiol 117, 573–582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Stoltz DA, Meyerholz DK, Pezzulo AA, Ramachandran S, Rogan MP, Davis GJ et al (2010). Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2, 29ra31–29ra31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Talley K & Alexov E (2010). On the pH‐optimum of activity and stability of proteins. Proteins Struct Funct Bioinforma 78, 2699–2706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tan CD, Hobbs C, Sameni M, Sloane BF, Stutts MJ & Tarran R (2014). Cathepsin B contributes to Na+ hyperabsorption in cystic fibrosis airway epithelial cultures. J Physiol 592, 5251–5268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Tarran R & Redinbo MR (2014). Mammalian short palate lung and nasal epithelial clone 1 (SPLUNC1) in pH‐dependent airway hydration. Int J Biochem Cell Biol 52, 130–135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tuo B, Riederer B, Wang Z, Colledge WH, Soleimani M & Seidler U (2006). Involvement of the anion exchanger SLC26A6 in prostaglandin E2‐ but not forskolin‐stimulated duodenal HCO3 secretion. Gastroenterology 130, 349–358. [DOI] [PubMed] [Google Scholar]
  43. Verdugo P (1991). Mucin exocytosis. Am Rev Respir Dis 144, S33–S37. [DOI] [PubMed] [Google Scholar]
  44. Zasloff M (1992). Antibiotic peptides as mediators of innate immunity. Curr Opin Immunol 4, 3–7. [DOI] [PubMed] [Google Scholar]
  45. Zhao Y & Encinosa W (2006). Gastroesophageal Reflux Disease (GERD) Hospitalizations in 1998 and 2005, Statistical Brief No. 44. Agency for Healthcare Research and Quality, Rockville, MD, USA. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb44.pdf. [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES